Still a hopeless case for personalized oncology? Pancreatic cancer revisited
Oncoscience
.
2018 Aug 22;6(1-2):285-286.
doi: 10.18632/oncoscience.464.
eCollection 2019 Jan.
Authors
Wilko Weichert
1
,
Martin R Sprick
1
,
Jens T Siveke
1
Affiliation
1
Member of the German Cancer Consortium (DKTK), Institute of Pathology, Technical University Munich, 81675 Munich, Germany.
PMID:
30800713
PMCID:
PMC6382256
DOI:
10.18632/oncoscience.464
No abstract available
Keywords:
RNA subtypes; ge-nomics; pancreatic cancer; personalized oncology; prognosis.